Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDA”

193 trials

Showing 20 of 193 results

Testing effectiveness (Phase 2)Looking for participantsNCT06561360
What this trial is testing

Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Who this might be right for
Hairy Cell Leukemia
Memorial Sloan Kettering Cancer Center 86
Testing effectiveness (Phase 2)Study completedNCT03531918
What this trial is testing

Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm

Who this might be right for
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 66
Post-approval studies (Phase 4)Active Not RecruitingNCT04178005
What this trial is testing

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

Who this might be right for
Multiple Sclerosis
University of Texas Southwestern Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT03602131
What this trial is testing

Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaNon-hodgkin Lymphoma
Sichuan University 30
Not applicableStudy completedNCT03403231
What this trial is testing

INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)

Who this might be right for
Prediabetes
VA Office of Research and Development 144
Not applicableStudy completedNCT03646656
What this trial is testing

Heart Health Buddies: Peer Support to Decrease CVD Risk

Who this might be right for
Cardiovascular Disease
VA Office of Research and Development 15
Testing effectiveness (Phase 2)Study completedNCT00483067
What this trial is testing

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 13
Not applicableStudy completedNCT06415864
What this trial is testing

Oral Cladribine B-cell Study

Who this might be right for
Multiple Sclerosis
Queen Mary University of London 10
Not applicableNot Yet RecruitingNCT06741202
What this trial is testing

Recovery-oriented Group Therapy for Veteran Men With Military Sexual Trauma

Who this might be right for
Sexual Trauma
VA Office of Research and Development 32
Not applicableNot Yet RecruitingNCT06682676
What this trial is testing

Diagnostic Efficacy of CDA Nasal Provocation Test in Patients With IR

Who this might be right for
Chronic Rhinitis
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05870995
What this trial is testing

Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia

Who this might be right for
Refractory Leukemia
Shanghai Jiao Tong University School of Medicine 100
Post-approval studies (Phase 4)UnknownNCT01795794
What this trial is testing

Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC

Who this might be right for
CDA Type I
Soroka University Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00002879
What this trial is testing

Cladribine in Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)Study completedNCT00003757
What this trial is testing

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

Who this might be right for
Leukemia
Swiss Cancer Institute 25
Post-approval studies (Phase 4)Study completedNCT03963375
What this trial is testing

Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Washington University School of Medicine 47
Large-scale testing (Phase 3)Study completedNCT00003746
What this trial is testing

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Who this might be right for
Leukemia
Swiss Cancer Institute 100
Not applicableActive Not RecruitingNCT05990075
What this trial is testing

An eHealth Intervention to Increase Depression Treatment Initiation and Adherence Among Veterans Referred for Mental Health Services

Who this might be right for
Depression
VA Office of Research and Development 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195945
What this trial is testing

CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

Who this might be right for
Acute Myeloid LeukemiaMyeloid Neoplasm
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT00003174
What this trial is testing

Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Barbara Ann Karmanos Cancer Institute 80
Not applicableWithdrawnNCT04504149
What this trial is testing

Shared Decision Making for PTSD in Primary Care

Who this might be right for
PTSD
VA Office of Research and Development
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation